Title : Targeting the adrenal gland in castration-resistant prostate cancer: a case for orteronel, a selective CYP-17 17,20-lyase inhibitor.

Pub. Date : 2013 Apr

PMID : 23371447






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A new CYP17 inhibitor, with more selective inhibition of 17,20-lyase over 17alpha-hydroxylase, orteronel (TAK-700), is currently undergoing phase III clinical trials in pre- and postchemotherapy CRPC. orteronel cytochrome P450 family 17 subfamily A member 1 Homo sapiens
2 A new CYP17 inhibitor, with more selective inhibition of 17,20-lyase over 17alpha-hydroxylase, orteronel (TAK-700), is currently undergoing phase III clinical trials in pre- and postchemotherapy CRPC. orteronel cytochrome P450 family 17 subfamily A member 1 Homo sapiens